This is evident from the loss of B-cell tolerance to PR3 as demonstrated by the presence of circulating PR3-ANCAs in GPA and the occurrence of a higher frequency of circulating PR3-specific B cells in GPA patients compared to healthy controls (HCs) [1, 12–14]. The gene discussed is PRTN3; the disease is granulomatosis with polyangiitis.